Search by Drug Name or NDC

    NDC 50090-1502-00 HAVRIX 1440 [iU]/mL Details

    HAVRIX 1440 [iU]/mL

    HAVRIX is a INTRAMUSCULAR INJECTION, SUSPENSION in the VACCINE category. It is labeled and distributed by A-S Medication Solutions. The primary component is HEPATITIS A VIRUS STRAIN HM175 ANTIGEN (FORMALDEHYDE INACTIVATED).

    Product Information

    NDC 50090-1502
    Product ID 50090-1502_23d4b1bc-00aa-4756-9bb0-74f36cbc9f6d
    Associated GPIs 17100008001840
    GCN Sequence Number 062760
    GCN Sequence Number Description hepatitis A virus vaccine/PF SYRINGE 1440/ML INTRAMUSC
    HIC3 W7B
    HIC3 Description VIRAL/TUMORIGENIC VACCINES
    GCN 98534
    HICL Sequence Number 034417
    HICL Sequence Number Description HEPATITIS A VIRUS VACCINE/PF
    Brand/Generic Generic
    Proprietary Name HAVRIX
    Proprietary Name Suffix n/a
    Non-Proprietary Name Hepatitis A Vaccine
    Product Type VACCINE
    Dosage Form INJECTION, SUSPENSION
    Route INTRAMUSCULAR
    Active Ingredient Strength 1440
    Active Ingredient Units [iU]/mL
    Substance Name HEPATITIS A VIRUS STRAIN HM175 ANTIGEN (FORMALDEHYDE INACTIVATED)
    Labeler Name A-S Medication Solutions
    Pharmaceutical Class Actively Acquired Immunity [PE], Hepatitis A Vaccines [CS], Inactivated Hepatitis A Virus Vaccine [EPC], Vaccines, Inactivated [CS]
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA103475
    Listing Certified Through 2024-12-31

    Package

    NDC 50090-1502-00 (50090150200)

    NDC Package Code 50090-1502-0
    Billing NDC 50090150200
    Package 10 SYRINGE in 1 CARTON (50090-1502-0) / 1 mL in 1 SYRINGE (50090-1502-9)
    Marketing Start Date 2007-04-13
    NDC Exclude Flag N
    Pricing Information N/A